ATXS vs BRSP
Comparison between Astria Therapeutics Inc (ATXS, Company) and BrightSpire Capital Inc - Class A (BRSP, Company).
ATXS is from the Healthcare sector, while BRSP is from the Real Estate sector.
5-Year PerformanceBRSP has outperformed ATXS, delivering a return of -1.2% compared to -5.1%
ATXS vs BRSP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ATXS vs BRSP - Historical Returns
Returns include dividend reinvestment.
ATXS vs BRSP - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | ATXS | BRSP |
|---|---|---|
| 2026 | -2.40% | +1.15% |
| 2025 | +45.93% | +10.80% |
| 2024 | +14.76% | -13.40% |
| 2023 | -48.94% | +33.01% |
| 2022 | +148.17% | -31.10% |
| 2021 | -60.07% | +53.82% |
| 2020 | -64.74% | -40.04% |
| 2019 | +33.41% | -7.05% |
| 2018 | -71.25% | -16.04% |
| 2017 | -59.73% | N/A |
| 2016 | -50.48% | N/A |
| 2015 | -39.00% | N/A |
ATXS vs BRSP Drawdown Comparison
The maximum drawdown for ATXS was -99.72%, occurring on Jun 16, 2022. This drawdown has not yet recovered.
The maximum drawdown for BRSP was -85.71%, occurring on Mar 20, 2020. This drawdown has not yet recovered.
The current ATXS drawdown is -98.55%. The current BRSP drawdown is -49.03%.
| Rank | ATXS | BRSP |
|---|---|---|
| #1 | -99.72% Jul 23, 2015 - Jun 16, 2022 | -85.71% Sep 21, 2018 - Mar 20, 2020 |
| #2 | -13.10% Jun 26, 2015 - Jul 6, 2015 | -12.11% Mar 9, 2018 - Jun 29, 2018 |
| #3 | -9.94% Jul 10, 2015 - Jul 23, 2015 | -9.56% Feb 1, 2018 - Feb 23, 2018 |
| #4 | -7.99% Jul 6, 2015 - Jul 10, 2015 | -7.18% Jul 13, 2018 - Sep 11, 2018 |
| #5 | N/A | -2.25% Mar 2, 2018 - Mar 7, 2018 |
| #6 | N/A | -1.82% Feb 28, 2018 - Mar 2, 2018 |
| #7 | N/A | -1.82% Jul 6, 2018 - Jul 13, 2018 |
| #8 | N/A | -0.78% Feb 23, 2018 - Feb 27, 2018 |
| #9 | N/A | -0.10% Jul 2, 2018 - Jul 5, 2018 |
Correlation
Correlation between ATXS and BRSP is 0.63 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks